Pamela Marcus, PhD, MS

Pamela Marcus is a Senior Scientist and Program Director in the Healthcare Delivery Research Program's (HDRP) Healthcare Assessment Research Branch (HARB). She manages grants that address clinical epidemiology and healthcare delivery issues across the cancer care continuum. Her primary research interests focus on the study of clinical evaluation in patients with suspected cancer. She is an expert in assessment of cancer screening modalities in both experimental and community settings, and is the author of Assessment of Cancer Screening: A Primer, an open-access textbook. Dr. Marcus also participates in DCCPS activities that support FAIR data sharing. Her professional development activities include enrollment in a 12-credit data science graduate program to build advanced skills in machine learning and deep learning.

Dr. Marcus began her career at NCI as a postdoctoral Cancer Prevention Fellow. From 1997 to 2011, she was a member of the Division of Cancer Prevention's Biometry Research Group. She was Lead Epidemiologist for the NCI component of the National Lung Screening Trial and published on operational aspects of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Dr. Marcus moved to the Applied Research Program (ARP) in NCI's Division of Cancer Control and Population Sciences (DCCPS) in 2011 and joined DCCPS’s Epidemiology and Genomics Research Program (EGRP) in 2013. During those years, she continued to manage cancer screening initiatives, including the Research Resource of the Breast Cancer Surveillance Consortium (BCSC), and explored emerging issues in cancer screening, such as risk-stratified screening. Dr. Marcus joined HARB in 2017 on half-time detail and transitioned to full membership in mid-2018.

Dr. Marcus received a PhD in Epidemiology from the University of North Carolina, Chapel Hill and an MS in Preventive Medicine and in Statistics from the University of Wisconsin–Madison. She also holds the accreditation of Board-certified Editor in the Life Sciences.